Role of cerebral cortex in the neuropathology of Huntington's disease
Open Access
- 1 January 2013
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Neural Circuits
- Vol. 7, 19
Abstract
An expansion of glutamine repeats in the N-terminal domain of the huntingtin protein leads to Huntington´s disease (HD), a neurodegenerative condition characterized by the presence of involuntary movements, dementia, and psychiatric disturbances. Evaluation of postmortem HD tissue indicates that the most prominent cell loss occurs in cerebral cortex and striatum, forebrain regions in which cortical pyramidal neurons (CPNs) and striatal medium spiny neurons (MSNs) are the most affected. Subsequent evidence obtained from HD patients and especially from transgenic mouse models of HD indicates that long before neuronal death, patterns of communication between CPNs and MSNs become dysfunctional. In fact, electrophysiological signaling in transgenic HD mice is altered even before the appearance of the HD behavioral phenotype, suggesting that dysfunctional cortical input to the striatum sets the stage for the emergence of HD neurological signs. Striatal MSNs, moreover, project back to cortex via multi-synaptic connections, allowing for even further disruptions in cortical processing. An effective therapeutic strategy for HD, therefore, may lie in understanding the synaptic mechanisms by which it dysregulates the corticostriatal system. Here, we review literature evaluating the molecular, morphological, and physiological alterations in the cerebral cortex, a key component of brain circuitry controlling motor behavior, as they occur in both patients and transgenic HD models.Keywords
This publication has 115 references indexed in Scilit:
- CAG‐repeat length and the age of onset in Huntington disease (HD): A review and validation study of statistical approachesAmerican Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2010
- Dysregulation of coordinated neuronal firing patterns in striatum of freely behaving transgenic rats that model Huntington's diseaseNeurobiology of Disease, 2010
- Full-length huntingtin levels modulate body weight by influencing insulin-like growth factor 1 expressionHuman Molecular Genetics, 2010
- Mouse models of Huntington's disease and methodological considerations for therapeutic trialsBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2009
- Progressive synaptic pathology of motor cortical neurons in a BAC transgenic mouse model of Huntington's diseaseNeuroscience, 2008
- Up-regulation of GLT1 expression increases glutamate uptake and attenuates the Huntington's disease phenotype in the R6/2 mouseNeuroscience, 2008
- Cerebral cortex and the clinical expression of Huntington's disease: complexity and heterogeneityBrain, 2008
- The corticostriatal pathway in Huntington's diseaseProgress in Neurobiology, 2007
- Selective defect of in vivo glycolysis in early Huntington's disease striatumProceedings of the National Academy of Sciences, 2007
- Viral delivery of glial cell line-derived neurotrophic factor improves behavior and protects striatal neurons in a mouse model of Huntington’s diseaseProceedings of the National Academy of Sciences, 2006